Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300/CBP inhibition

The Sequence Alignment/Map format and SAMtools

Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041 · see citing works

Fast gapped-read alignment with Bowtie 2

Langmead, B., & Salzberg, S. L. (2012) · Nature Methods · doi:10.1038/nmeth.1923 · Cited by 56,400 · see citing works

Cutadapt removes adapter sequences from high-throughput sequencing reads

Martin, M. (2011) · EMBnet.journal · doi:10.14806/ej.17.1.200 · Cited by 33,889 · see citing works

featureCounts: an efficient general purpose program for assigning sequence reads to genomic features

Liao, Y., Smyth, G. K., & Shi, W. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt656 · Cited by 27,219 · see citing works

HISAT: a fast spliced aligner with low memory requirements

Kim, D., Langmead, B., & Salzberg, S. L. (2015) · Nature Methods · doi:10.1038/nmeth.3317 · Cited by 24,112 · see citing works

Model-based Analysis of ChIP-Seq (MACS)

Zhang, Y., Liu, T., Meyer, C. A., Eeckhoute, J., Johnson, D. S., Bernstein, B. E., Nusbaum, C., Myers, R. M., Brown, M., Li, W., et al. (2008) · Genome Biology · doi:10.1186/gb-2008-9-9-r137 · Cited by 18,386 · see citing works

An integrated encyclopedia of DNA elements in the human genome

The ENCODE Project Consortium (2012) · Nature · doi:10.1038/nature11247 · Cited by 18,072 · see citing works

Simple Combinations of Lineage-Determining Transcription Factors Prime cis-Regulatory Elements Required for Macrophage and B Cell Identities

Heinz, S., Benner, C., Spann, N., Bertolino, E., Lin, Y. C., Laslo, P., Cheng, J. X., Murre, C., Singh, H., & Glass, C. K. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.004 · Cited by 13,382 · see citing works

Fast, sensitive and accurate integration of single-cell data with Harmony

Korsunsky, I., Millard, N., Fan, J., Slowikowski, K., Zhang, F., Wei, K., Baglaenko, Y., Brenner, M., Loh, P.-R., & Raychaudhuri, S. (2019) · Nature Methods · doi:10.1038/s41592-019-0619-0 · Cited by 10,488 · see citing works

A 3D Map of the Human Genome at Kilobase Resolution Reveals Principles of Chromatin Looping

Rao, S. S. P., Huntley, M. H., Durand, N. C., Stamenova, E. K., Bochkov, I. D., Robinson, J. T., Sanborn, A. L., Machol, I., Omer, A. D., Lander, E. S., et al. (2014) · Cell · doi:10.1016/j.cell.2014.11.021 · Cited by 9,212 · see citing works

Comprehensive Mapping of Long-Range Interactions Reveals Folding Principles of the Human Genome

Lieberman-Aiden, E., van Berkum, N. L., Williams, L., Imakaev, M., Ragoczy, T., Telling, A., Amit, I., Lajoie, B. R., Sabo, P. J., Dorschner, M. O., et al. (2009) · Science · doi:10.1126/science.1181369 · Cited by 8,898 · see citing works

voom: precision weights unlock linear model analysis tools for RNA-seq read counts

Law, C. W., Chen, Y., Shi, W., & Smyth, G. K. (2014) · Genome Biology · doi:10.1186/gb-2014-15-2-r29 · Cited by 6,155 · see citing works

Improved vectors and genome-wide libraries for CRISPR screening

Sanjana, N. E., Shalem, O., & Zhang, F. (2014) · Nature Methods · doi:10.1038/nmeth.3047 · Cited by 5,239 · see citing works

Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation

McCarthy, D. J., Chen, Y., & Smyth, G. K. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks042 · Cited by 5,195 · see citing works

Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma

Patel, A. P., Tirosh, I., Trombetta, J. J., Shalek, A. K., Gillespie, S. M., Wakimoto, H., Cahill, D. P., Nahed, B. V., Curry, W. T., Martuza, R. L., et al. (2014) · Science · doi:10.1126/science.1254257 · Cited by 5,063 · see citing works

Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9

Doench, J. G., Fusi, N., Sullender, M., Hegde, M., Vaimberg, E. W., Donovan, K. F., Smith, I., Tothova, Z., Wilen, C., Orchard, R., et al. (2016) · Nature Biotechnology · doi:10.1038/nbt.3437 · Cited by 4,637 · see citing works

Core Transcriptional Regulatory Circuitry in Human Embryonic Stem Cells

Boyer, L. A., Lee, T. I., Cole, M. F., Johnstone, S. E., Levine, S. S., Zucker, J. P., Guenther, M. G., Kumar, R. M., Murray, H. L., Jenner, R. G., et al. (2005) · Cell · doi:10.1016/j.cell.2005.08.020 · Cited by 4,505 · see citing works

deepTools: a flexible platform for exploring deep-sequencing data

Ramírez, F., Dündar, F., Diehl, S., Grüning, B. A., & Manke, T. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku365 · Cited by 3,738 · see citing works

Defining a Cancer Dependency Map

Tsherniak, A., Vazquez, F., Montgomery, P. G., Weir, B. A., Kryukov, G., Cowley, G. S., Gill, S., Harrington, W. F., Pantel, S., Krill-Burger, J. M., et al. (2017) · Cell · doi:10.1016/j.cell.2017.06.010 · Cited by 3,276 · see citing works

The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote

Liao, Y., Smyth, G. K., & Shi, W. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt214 · Cited by 3,064 · see citing works

The Transcriptional Coactivators p300 and CBP Are Histone Acetyltransferases

Ogryzko, V. V., Schiltz, R. L., Russanova, V., Howard, B. H., & Nakatani, Y. (1996) · Cell · doi:10.1016/s0092-8674(00)82001-2 · Cited by 2,952 · see citing works

BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc

Delmore, J. E., Issa, G. C., Lemieux, M. E., Rahl, P. B., Shi, J., Jacobs, H. M., Kastritis, E., Gilpatrick, T., Paranal, R. M., Qi, J., et al. (2011) · Cell · doi:10.1016/j.cell.2011.08.017 · Cited by 2,820 · see citing works

MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens

Li, W., Xu, H., Xiao, T., Cong, L., Love, M. I., Zhang, F., Irizarry, R. A., Liu, J. S., Brown, M., & Liu, X. S. (2014) · Genome Biology · doi:10.1186/s13059-014-0554-4 · Cited by 2,684 · see citing works

An improved ATAC-seq protocol reduces background and enables interrogation of frozen tissues

Corces, M. R., Trevino, A. E., Hamilton, E. G., Greenside, P. G., Sinnott-Armstrong, N. A., Vesuna, S., Satpathy, A. T., Rubin, A. J., Montine, K. S., Wu, B., et al. (2017) · Nature Methods · doi:10.1038/nmeth.4396 · Cited by 2,496 · see citing works

The CBP co-activator is a histone acetyltransferase

Bannister, A. J., & Kouzarides, T. (1996) · Nature · doi:10.1038/384641a0 · Cited by 1,824 · see citing works

Structure and ligand of a histone acetyltransferase bromodomain

Dhalluin, C., Carlson, J. E., Zeng, L., He, C., Aggarwal, A. K., Zhou, M.-M., & Zhou, M.-M. (1999) · Nature · doi:10.1038/20974 · Cited by 1,732 · see citing works

Inhibition of PRC2 Activity by a Gain-of-Function H3 Mutation Found in Pediatric Glioblastoma

Lewis, P. W., Müller, M. M., Koletsky, M. S., Cordero, F., Lin, S., Banaszynski, L. A., Garcia, B. A., Muir, T. W., Becher, O. J., & Allis, C. D. (2013) · Science · doi:10.1126/science.1232245 · Cited by 1,345 · see citing works

The Bromodomain Protein Brd4 Is a Positive Regulatory Component of P-TEFb and Stimulates RNA Polymerase II-Dependent Transcription

Jang, M. K., Mochizuki, K., Zhou, M., Jeong, H., Brady, J. N., & Ozato, K. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.06.027 · Cited by 1,301 · see citing works

Single-cell RNA-seq supports a developmental hierarchy in human oligodendroglioma

Tirosh, I., Venteicher, A. S., Hebert, C. M., Escalante, L. E., Patel, A. P., Yizhak, K., Fisher, J. M., Rodman, C., Mount, C., Filbin, M. G., et al. (2016) · Nature · doi:10.1038/nature20123 · Cited by 1,216 · see citing works

Transcriptional Addiction in Cancer

Bradner, J. E., Hnisz, D., & Young, R. A. (2017) · Cell · doi:10.1016/j.cell.2016.12.013 · Cited by 1,188 · see citing works

Recruitment of P-TEFb for Stimulation of Transcriptional Elongation by the Bromodomain Protein Brd4

Yang, Z., Yik, J. H. N., Chen, R., He, N., Jang, M. K., Ozato, K., & Zhou, Q. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.06.029 · Cited by 1,141 · see citing works

Robust hyperparameter estimation protects against hypervariable genes and improves power to detect differential expression

Phipson, B., Lee, S., Majewski, I. J., Alexander, W. S., & Smyth, G. K. (2016) · The Annals of Applied Statistics · doi:10.1214/16-aoas920 · Cited by 966 · see citing works

Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours

Lasko, L. M., Jakob, C. G., Edalji, R. P., Qiu, W., Montgomery, D., Digiammarino, E. L., Hansen, T. M., Risi, R. M., Frey, R., Manaves, V., et al. (2017) · Nature · doi:10.1038/nature24028 · Cited by 858 · see citing works

IRF4 addiction in multiple myeloma

Shaffer, A. L., Emre, N. C. T., Lamy, L., Ngo, V. N., Wright, G., Xiao, W., Powell, J., Dave, S., Yu, X., Zhao, H., et al. (2008) · Nature · doi:10.1038/nature07064 · Cited by 730 · see citing works

The double bromodomain protein Brd4 binds to acetylated chromatin during interphase and mitosis

Dey, A., Chitsaz, F., Abbasi, A., Misteli, T., & Ozato, K. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1433065100 · Cited by 672 · see citing works

Targeting the epigenetic regulation of antitumour immunity

Hogg, S. J., Beavis, P. A., Dawson, M. A., & Johnstone, R. W. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0077-5 · Cited by 653 · see citing works

The SMRT and N-CoR Corepressors Are Activating Cofactors for Histone Deacetylase 3

Guenther, M. G., Barak, O., & Lazar, M. A. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.18.6091-6101.2001 · Cited by 611 · see citing works

Functions of bromodomain-containing proteins and their roles in homeostasis and cancer

Fujisawa, T., & Filippakopoulos, P. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.143 · Cited by 589 · see citing works

HDAC8 mutations in Cornelia de Lange syndrome affect the cohesin acetylation cycle

Deardorff, M. A., Bando, M., Nakato, R., Watrin, E., Itoh, T., Minamino, M., Saitoh, K., Komata, M., Katou, Y., Clark, D., et al. (2012) · Nature · doi:10.1038/nature11316 · Cited by 577 · see citing works

CBP-mediated acetylation of histone H3 lysine 27 antagonizesDrosophilaPolycomb silencing

Tie, F., Banerjee, R., Stratton, C. A., Prasad-Sinha, J., Stepanik, V. A., Zlobin, A., Dı́az, M. O., Scacheri, P. C., & Harte, P. J. (2009) · Development · doi:10.1242/dev.037127 · Cited by 575 · see citing works

Chromatin disruption and modification

Wolffe, A. P., & Hayes, J. J. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.3.711 · Cited by 551 · see citing works

Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferation

Qi, W., Chan, H., Teng, L., Li, L., Chuai, S., Zhang, R., Zeng, J., Li, M., Fan, H. X., Lin, Y., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1210371110 · Cited by 550 · see citing works

Epigenetic balance of gene expression by Polycomb and COMPASS families

Piunti, A., & Shilatifard, A. (2016) · Science · doi:10.1126/science.aad9780 · Cited by 524 · see citing works

Time-Resolved Analysis Reveals Rapid Dynamics and Broad Scope of the CBP/p300 Acetylome

Weinert, B. T., Narita, T., Satpathy, S., Srinivasan, B., Hansen, B. K., Scholz, C. W., Hamilton, W. B., Zucconi, B. E., Wang, W., Liu, W. R., et al. (2018) · Cell · doi:10.1016/j.cell.2018.04.033 · Cited by 514 · see citing works

csaw: a Bioconductor package for differential binding analysis of ChIP-seq data using sliding windows

Lun, A. T. L., & Smyth, G. K. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1191 · Cited by 510 · see citing works

Quantitative ChIP-Seq normalization reveals global modulation of the epigenome

Orlando, D. A., Chen, M. W., Brown, V. E., Solanki, S., Choi, Y. J., Olson, E. R., Fritz, C. C., Bradner, J. E., & Guenther, M. G. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.10.018 · Cited by 503 · see citing works

Eco1-Dependent Cohesin Acetylation During Establishment of Sister Chromatid Cohesion

Ben-Shahar, T. R., Heeger, S., Lehane, C., East, P., Flynn, H. R., Skehel, M. J., & Uhlmann, F. (2008) · Science · doi:10.1126/science.1157774 · Cited by 498 · see citing works

BET Bromodomain Proteins Function as Master Transcription Elongation Factors Independent of CDK9 Recruitment

Winter, G. E., Mayer, A., Buckley, D. L., Erb, M. A., Roderick, J. E., Vittori, S., Reyes, J. M., di Iulio, J., Souza, A., Ott, C. J., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.06.004 · Cited by 465 · see citing works

A Molecular Determinant for the Establishment of Sister Chromatid Cohesion

Ünal, E., Heidinger-Pauli, J. M., Kim, W., Guacci, V., Onn, I., Gygi, S. P., & Koshland, D. E. (2008) · Science · doi:10.1126/science.1157880 · Cited by 460 · see citing works

Comprehensive analysis of single cell ATAC-seq data with SnapATAC

Fang, R., Preissl, S., Li, Y., Hou, X., Lucero, J., Wang, X., Motamedi, A., Shiau, A. K., Zhou, X., Xie, F., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21583-9 · Cited by 455 · see citing works

Maintaining cell identity: PRC2-mediated regulation of transcription and cancer

Comet, I. V., Riising, E. M., Leblanc, B., & Helin, K. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.83 · Cited by 428 · see citing works

Characterization of an antagonistic switch between histone H3 lysine 27 methylation and acetylation in the transcriptional regulation of Polycomb group target genes

Pasini, D., Malatesta, M., Jung, H. R., Walfridsson, J., Willer, A., Olsson, L., Skotte, J., Wutz, A., Porse, B. T., Jensen, O. N., et al. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq244 · Cited by 399 · see citing works

An Inducible Lentiviral Guide RNA Platform Enables the Identification of Tumor-Essential Genes and Tumor-Promoting Mutations In Vivo

Aubrey, B. J., Kelly, G. L., Kueh, A. J., Brennan, M. S., O’Connor, L., Milla, L., Wilcox, S., Tai, L., Strasser, A., & Herold, M. J. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.02.002 · Cited by 384 · see citing works

BET Bromodomain Inhibition Suppresses the Function of Hematopoietic Transcription Factors in Acute Myeloid Leukemia

Roe, J., Mercan, F., Rivera, K. D., Pappin, D., & Vakoc, C. R. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.04.011 · Cited by 332 · see citing works

Detecting Differential Expression in RNA-sequence Data Using Quasi-likelihood with Shrunken Dispersion Estimates

Lund, S. P., Nettleton, D. S., McCarthy, D. J., & Smyth, G. K. (2012) · Statistical Applications in Genetics and Molecular Biology · doi:10.1515/1544-6115.1826 · Cited by 322 · see citing works

BET-Bromodomain Inhibitors Engage the Host Immune System and Regulate Expression of the Immune Checkpoint Ligand PD-L1

Hogg, S. J., Vervoort, S. J., Deswal, S., Ott, C. J., Li, J., Cluse, L. A., Beavis, P. A., Darcy, P. K., Martin, B. P., Spencer, A., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.02.011 · Cited by 308 · see citing works

Models of human core transcriptional regulatory circuitriesPreprint

Saint‐André, V., Alexander Joel Federation, Lin, C. Y., Abraham, B. J., Reddy, J., Lee, T. I., Bradner, J. E., & Young, R. A. (2016) · Genome Research · doi:10.1101/gr.197590.115 · Cited by 290 · see citing works

Selective gene dependencies in MYCN-amplified neuroblastoma include the core transcriptional regulatory circuitry

Durbin, A. D., Zimmerman, M. W., Dharia, N. V., Abraham, B. J., Iniguez, A. B., Weichert‐Leahey, N., He, S., Krill-Burger, J. M., Root, D. E., Vázquez, F., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0191-z · Cited by 282 · see citing works

<i>CREBBP</i> Inactivation Promotes the Development of HDAC3-Dependent Lymphomas

Jiang, Y., Ortega-Molina, A., Geng, H., Ying, H.-Y., Hatzi, K., Parsa, S., McNally, D., Wang, L., Doane, A. S., Agirre, X., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0975 · Cited by 278 · see citing works

RNAi-dependent H3K27 methylation is required for heterochromatin formation and DNA elimination in TetrahymenaPreprint

Liu, Y., Taverna, S. D., Muratore‐Schroeder, T. L., Shabanowitz, J., Hunt, D. F., & Allis, C. D. (2007) · Genes & Development · doi:10.1101/gad.1544207 · Cited by 257 · see citing works

Deacetylase-Independent Function of HDAC3 in Transcription and Metabolism Requires Nuclear Receptor Corepressor

Sun, Z., Feng, D., Fang, B., Mullican, S. E., You, S.-H., Lim, H., Everett, L. J., Nabel, C. S., Li, Y., Selvakumaran, V., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.10.022 · Cited by 247 · see citing works

Enhancers are activated by p300/CBP activity-dependent PIC assembly, RNAPII recruitment, and pause release

Narita, T., Ito, S., Higashijima, Y., Chu, W. K., Neumann, K., Walter, J., Satpathy, S., Liebner, T., Hamilton, W. B., Maskey, E., et al. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.03.008 · Cited by 228 · see citing works

HDAC3: taking the SMRT-N-CoRrect road to repression

Karagianni, P., & Wong, J. (2007) · Oncogene · doi:10.1038/sj.onc.1210612 · Cited by 221 · see citing works

Accurate H3K27 methylation can be established de novo by SUZ12-directed PRC2

Højfeldt, J. W., Laugesen, A., Willumsen, B. M., Damhofer, H., Hedehus, L., Tvardovskiy, A., Mohammad, F., Jensen, O. N., & Helin, K. (2018) · Nature Structural & Molecular Biology · doi:10.1038/s41594-018-0036-6 · Cited by 219 · see citing works

diffHic: a Bioconductor package to detect differential genomic interactions in Hi-C data

Lun, A. T. L., & Smyth, G. K. (2015) · BMC Bioinformatics · doi:10.1186/s12859-015-0683-0 · Cited by 199 · see citing works

Sushi.R: flexible, quantitative and integrative genomic visualizations for publication-quality multi-panel figures

Phanstiel, D. H., Boyle, A. P., Araya, C. L., & Snyder, M. P. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu379 · Cited by 179 · see citing works

Unique and Shared Epigenetic Programs of the CREBBP and EP300 Acetyltransferases in Germinal Center B Cells Reveal Targetable Dependencies in Lymphoma

Meyer, S. N., Scuoppo, C., Vlasevska, S., Bal, É., Holmes, A. B., Holloman, M., Garcia‐Ibanez, L., Nataraj, S. E., Duval, R., Vantrimpont, T., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.08.006 · Cited by 153 · see citing works

Histone hyperacetylation disrupts core gene regulatory architecture in rhabdomyosarcoma

Gryder, B., Pomella, S., Sayers, C. M., Wu, X.-L. S., Song, Y., Chiarella, A. M., Bagchi, S., Chou, H.-C., Sinniah, R., Walton, A., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0534-4 · Cited by 151 · see citing works

Histone Demethylase UTX and Chromatin Remodeler BRM Bind Directly to CBP and Modulate Acetylation of Histone H3 Lysine 27

Tie, F., Banerjee, R., Conrad, P. A., Scacheri, P. C., & Harte, P. J. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06392-11 · Cited by 146 · see citing works

Chemical genomics reveals histone deacetylases are required for core regulatory transcription

Gryder, B. E., Wu, L., Woldemichael, G. M., Pomella, S., Quinn, T. R., Park, P. M. C., Cleveland, A. H., Stanton, B. Z., Song, Y., Rota, R., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11046-7 · Cited by 143 · see citing works

SCAF4 and SCAF8, mRNA Anti-Terminator Proteins

Gregersen, L. H., Mitter, R., Ugalde, A. P., Nojima, T., Proudfoot, N. J., Agami, R., Stewart, A., & Svejstrup, J. Q. (2019) · Cell · doi:10.1016/j.cell.2019.04.038 · Cited by 140 · see citing works

UTX/KDM6A Loss Enhances the Malignant Phenotype of Multiple Myeloma and Sensitizes Cells to EZH2 inhibition

Ezponda, T., Dupéré-Richer, D., Will, C., Small, E. C., Varghese, N., Patel, T., Nabet, B., Popovic, R., Oyer, J. A., Bulic, M., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.09.078 · Cited by 139 · see citing works

Drosophila UTX Is a Histone H3 Lys27 Demethylase That Colocalizes with the Elongating Form of RNA Polymerase II

Smith, E. R., Lee, M. G., Winter, B., Droz, N. M., Eissenberg, J. C., Shiekhattar, R., & Shilatifard, A. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01504-07 · Cited by 129 · see citing works

Loss of HP1 causes depletion of H3K27me3 from facultative heterochromatin and gain of H3K27me2 at constitutive heterochromatinPreprint

Jamieson, K., Wiles, E. T., McNaught, K. J., Sidoli, S., Leggett, N. A., Shao, Y., Garcia, B. A., & Selker, E. U. (2015) · Genome Research · doi:10.1101/gr.194555.115 · Cited by 128 · see citing works

KDM6 Demethylase Independent Loss of Histone H3 Lysine 27 Trimethylation during Early Embryonic Development

Shpargel, K. B., Starmer, J., Yee, D., Pohlers, M., & Magnuson, T. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004507 · Cited by 124 · see citing works

Transcription-factor-mediated supervision of global genome architecture maintains B cell identity

Johanson, T. M., Lun, A. T. L., Coughlan, H. D., Tan, T., Smyth, G. K., Nutt, S. L., & Allan, R. S. (2018) · Nature Immunology · doi:10.1038/s41590-018-0234-8 · Cited by 104 · see citing works

Molecular Pathways: Deregulation of Histone H3 Lysine 27 Methylation in Cancer—Different Paths, Same Destination

Ezponda, T., & Licht, J. D. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2499 · Cited by 96 · see citing works

Reconstitution of hyperacetylated, DNase I-sensitive chromatin characterized by high conformational flexibility of nucleosomal DNA

Krajewski, W. A., & Becker, P. B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.4.1540 · Cited by 93 · see citing works

H3K27ac bookmarking promotes rapid post-mitotic activation of the pluripotent stem cell program without impacting 3D chromatin reorganization

Pelham-Webb, B., Polyzos, A., Wojenski, L., Kloetgen, A., Li, J.-X., Giammartino, D. C. D., Sakellaropoulos, T., Tsirigos, A., Core, L., & Apostolou, E. (2021) · Molecules and Cells · doi:10.1016/j.molcel.2021.02.032 · Cited by 92 · see citing works

BET Inhibition Induces Apoptosis in Aggressive B-Cell Lymphoma via Epigenetic Regulation of BCL-2 Family Members

Hogg, S. J., Newbold, A., Vervoort, S. J., Cluse, L. A., Martin, B. P., Gregory, G. P., Lefebure, M., Vidacs, E., Tothill, R. W., Bradner, J. E., et al. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0924 · Cited by 71 · see citing works

Functional-genetic dissection of HDAC dependencies in mouse lymphoid and myeloid malignancies

Matthews, G. M., Mehdipour, P., Cluse, L. A., Falkenberg, K. J., Wang, E., Roth, M., Santoro, F., Vidacs, E., Stanley, K. L., House, C. M., et al. (2015) · Blood · doi:10.1182/blood-2015-03-632984 · Cited by 60 · see citing works

Thermal Denaturation Studies of Acetylated Nucleosomes and Oligonucleosmes

Yau, P. M., Thorne, A. W., Imai, B. S., Matthews, H. R., & Bradbury, E. M. (1982) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1982.tb07050.x · Cited by 55 · see citing works

dbCoRC: a database of core transcriptional regulatory circuitries modeled by H3K27ac ChIP-seq signals

Huang, M., Chen, Y., Yang, M., Guo, A., Xu, Y., Xu, L., & Koeffler, H. P. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx796 · Cited by 41 · see citing works

Interaction between N-terminal domain of H4 and DNA is regulated by the acetylation degree

Puig, Ó., Bellés, E., López‐Rodas, G., Sendra, R., & Tordera, V. (1998) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(98)00008-6 · Cited by 22 · see citing works

Discovery of spirohydantoins as selective, orally bioavailable inhibitors of p300/CBP histone acetyltransferases

Ji, Z., Clark, R. F., Bhat, V., Hansen, T. M., Lasko, L. M., Bromberg, K. D., Manaves, V., Algire, M. A., Martin, R. L., Qiu, W., et al. (2021) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2021.127854 · Cited by 22 · see citing works

Untitled work

(1998) · doi:10.1002/(sici)1521-1878(199808)20:8

Modulation of cellular processes by histone and non-histone protein acetylation

Shvedunova, M., & Akhtar, A. (2022) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00441-y · Cited by 975 · see citing works

Histone acetyltransferases CBP/p300 in tumorigenesis and CBP/p300 inhibitors as promising novel anticancer agents

Chen, Q., Yang, B.-H., Liu, X., Zhang, X. D., Zhang, L., & Liu, T. (2022) · Theranostics · doi:10.7150/thno.73223 · Cited by 272 · see citing works

Circulating tumor cells: from new biological insights to clinical practice

Gu, X., Wei, S., & Lv, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01938-6 · Cited by 196 · see citing works

Targeting transcription cycles in cancer

Vervoort, S., Devlin, J., Kwiatkowski, N., Teng, M.-X., Gray, N., & Johnstone, R. (2021) · Nature Reviews. Cancer · doi:10.1038/s41568-021-00411-8 · Cited by 140 · see citing works

Chromatin accessibility: methods, mechanisms, and biological insights

Mansisidor, A., & Risca, V. I. (2022) · Nucleus · doi:10.1080/19491034.2022.2143106 · Cited by 150 · see citing works

LPCAT3 Is Transcriptionally Regulated by YAP/ZEB/EP300 and Collaborates with ACSL4 and YAP to Determine Ferroptosis Sensitivity

Cui, J., Wang, Y., Tian, X., Miao, Y., Ma, L., Zhang, C., Xu, X., Wang, J., Fang, W., & Zhang, X. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2023.0237 · Cited by 131 · see citing works

Epigenetic regulation in cancer

Gu, M., Ren, B., Fang, Y., Ren, J., Liu, X., Wang, X., Zhou, F., Xiao, R., Luo, X., You, L., et al. (2024) · MedComm · doi:10.1002/mco2.495 · Cited by 119 · see citing works

CBP/p300: Critical Co-Activators for Nuclear Steroid Hormone Receptors and Emerging Therapeutic Targets in Prostate and Breast Cancers

Waddell, A. R., Huang, H., & Liao, D. (2021) · Cancers · doi:10.3390/cancers13122872 · Cited by 110 · see citing works

Now open: Evolving insights to the roles of lysine acetylation in chromatin organization and function

Chen, Y.-J. C., Koutelou, E., & Dent, S. (2022) · Molecular Cell · doi:10.1016/j.molcel.2021.12.004 · Cited by 107 · see citing works

The Role of CREBBP/EP300 and Its Therapeutic Implications in Hematological Malignancies

Zhu, Y., Wang, Z., Li, Y., Peng, H., Liu, J., Zhang, J., & Xiao, X. (2023) · Cancers · doi:10.3390/cancers15041219 · Cited by 100 · see citing works

Mechanisms and cross-talk of regulated cell death and their epigenetic modifications in tumor progression

He, R., Liu, Y., Fu, W., He, X., Liu, S., Xiao, D., & Tao, Y. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02172-y · Cited by 99 · see citing works

Effects of the Acetyltransferase p300 on Tumour Regulation from the Novel Perspective of Posttranslational Protein Modification

Zeng, Q.-M., Wang, K., Zhao, Y., Ma, Q., Chen, Z., & Huang, W. (2023) · Biomolecules · doi:10.3390/biom13030417 · Cited by 79 · see citing works

Structural insights into p300 regulation and acetylation-dependent genome organisation

Ibrahim, Z., Wang, T., Destaing, O., Salvi, N., Hoghoughi, N., Chabert, C., Rusu, A., Gao, J., Feletto, L., Reynoird, N., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-35375-2 · Cited by 64 · see citing works

Epigenetic moonlighting: Catalytic-independent functions of histone modifiers in regulating transcription

Morgan, M. A., & Shilatifard, A. (2023) · Science Advances · doi:10.1126/sciadv.adg6593 · Cited by 65 · see citing works

Targeting lysine acetylation readers and writers

Zhou, M., & Cole, P. A. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-01080-6 · Cited by 62 · see citing works

Targeting epigenetic modulators using PROTAC degraders: Current status and future perspective

Webb, T., Craigon, C., & Ciulli, A. (2022) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2022.128653 · Cited by 58 · see citing works

Pharmacological targeting of the cancer epigenome

Mabe, N. W., Perry, J. A., Malone, C. F., & Stegmaier, K. (2024) · Nature Cancer · doi:10.1038/s43018-024-00777-2 · Cited by 58 · see citing works

Acetyl-CoA metabolism as a therapeutic target for cancer

Chen, G., Bao, B., Cheng, Y., Tian, M., Song, J., Zheng, L., & Tong, Q. (2023) · Biomedicine &amp; Pharmacotherapy · doi:10.1016/j.biopha.2023.115741 · Cited by 54 · see citing works

HDACs and the epigenetic plasticity of cancer cells: target the complexity

Brancolini, C., Gagliano, T., & Minisini, M. (2022) · Pharmacology &amp; Therapeutics · doi:10.1016/j.pharmthera.2022.108190 · Cited by 55 · see citing works

HDAC3 and HDAC8 PROTAC dual degrader reveals roles of histone acetylation in gene regulation

Xiao, Y., Hale, S. M., Awasthee, N., Meng, C., Zhang, X., Liu, Y., Ding, H., Huo, Z., Lv, D., Zhang, W., et al. (2023) · Cell chemical biology · doi:10.1016/j.chembiol.2023.07.010 · Cited by 54 · see citing works

Autoimmune disease: a view of epigenetics and therapeutic targeting

Mu, S., Wang, W., Liu, Q., Ke, N., Li, H., Sun, F., Zhang, J., & Zhu, Z. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1482728 · Cited by 57 · see citing works

Proteomic characterization of post-translational modifications in drug discovery

Zhai, L., Chen, K., Hao, B., & Tan, M. (2022) · Acta Pharmacologica Sinica · doi:10.1038/s41401-022-01017-y · Cited by 50 · see citing works

Protein lysine acetyltransferase CBP/p300: A promising target for small molecules in cancer treatment

Gou, P., & Zhang, W. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116130 · Cited by 53 · see citing works

Enhancer reprogramming: critical roles in cancer and promising therapeutic strategies

Yang, J., Zhou, F., Luo, X., Fang, Y., Wang, X., Liu, X., Xiao, R., Jiang, D., Tang, Y., Yang, G., et al. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02366-3 · Cited by 50 · see citing works

The role of protein acetylation in carcinogenesis and targeted drug discovery

Yang, J., Song, C., & Zhan, X. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.972312 · Cited by 42 · see citing works

Transcriptional Heterogeneity Overcomes Super-Enhancer Disrupting Drug Combinations in Multiple Myeloma

Welsh, S. J., Barwick, B. G., Meermeier, E. W., Riggs, D. L., Shi, C.-X., Zhu, Y. X., Sharik, M. E., Du, M. T., Rocha, L. D. A., Garbitt, V. M., et al. (2023) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-23-0062 · Cited by 44 · see citing works

Emerging Pharmacotherapeutic Strategies to Overcome Undruggable Proteins in Cancer

Lu, Y., Yang, Y., Zhu, G., Zeng, H., Fan, Y., Guo, F., Xu, D., Wang, B., Chen, D., & Ge, G. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.83026 · Cited by 41 · see citing works

Acetyl-CoA biosynthesis drives resistance to histone acetyltransferase inhibition

Bishop, T. R., Subramanian, C., Bilotta, E. M., Garnar-Wortzel, L., Ramos, A. R., Zhang, Y., Asiaban, J. N., Ott, C. J., Rock, C. O., & Erb, M. A. (2023) · Nature Chemical Biology · doi:10.1038/s41589-023-01320-7 · Cited by 39 · see citing works

Small molecule targeting of chromatin writers in cancer

Conery, A. R., Rocnik, J. L., & Trojer, P. (2021) · Nature Chemical Biology · doi:10.1038/s41589-021-00920-5 · Cited by 36 · see citing works

ETV4-Dependent Transcriptional Plasticity Maintains MYC Expression and Results in IMiD Resistance in Multiple Myeloma

Neri, P. E., Barwick, B. G., Jung, D., Patton, J. C., Maity, R., Tagoug, I., Stein, C. K., Tilmont, R., Leblay, N., Ahn, S., et al. (2023) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-23-0061 · Cited by 34 · see citing works

CRISPR screens identify gene targets at breast cancer risk loci

Tuano, N. K., Beesley, J., Manning, M., Shi, W., Perlaza-Jimenez, L., Malaver-Ortega, L. F., Paynter, J. M., Black, D., Civitarese, A., McCue, K., et al. (2023) · Genome Biology · doi:10.1186/s13059-023-02898-w · Cited by 30 · see citing works

Targeting histone H2B acetylated enhanceosomes via p300/CBP degradation in prostate cancer

Luo, J., Chen, Z., Qiao, Y., Tien, J. C.-Y., Young, E., Mannan, R., Mahapatra, S., Bhattacharyya, R., Xiao, L., He, T., et al. (2025) · Nature Genetics · doi:10.1038/s41588-025-02336-6 · Cited by 34 · see citing works

Dietary Fiber‐Derived Microbial Butyrate Suppresses ILC2‐Dependent Airway Inflammation in COPD

Jiang, M., Wang, J., Li, Z., Xu, D., Jing, J., Li, F., Ding, J., & Li, Q. (2024) · Mediators of Inflammation · doi:10.1155/2024/6263447 · Cited by 34 · see citing works

The roles of lactate and the interplay with m6A modification in diseases

Tang, F., Xiao, D., Li, X., & Qiao, L. (2024) · Cell Biology and Toxicology · doi:10.1007/s10565-024-09951-9 · Cited by 32 · see citing works

KATs off: Biomedical insights from lysine acetyltransferase inhibitors

Whedon, S. D., & Cole, P. A. (2022) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2022.102255 · Cited by 32 · see citing works

PAX3-FOXO1 uses its activation domain to recruit CBP/P300 and shape RNA Pol2 cluster distribution

Asante, Y., Benischke, K., Osman, I., Ngo, Q., Wurth, J., Laubscher, D., Kim, H., Udhayakumar, B., Khan, M. I. H., Chin, D. H., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43780-4 · Cited by 31 · see citing works

The important role of the histone acetyltransferases p300/CBP in cancer and the promising anticancer effects of p300/CBP inhibitors

Wu, X., Zhang, X., Tang, S., & Wang, Y. (2025) · Cell Biology and Toxicology · doi:10.1007/s10565-024-09984-0 · Cited by 28 · see citing works

Molecular Mechanisms of Cereblon-Interacting Small Molecules in Multiple Myeloma Therapy

Costacurta, M., He, J., Thompson, P. E., & Shortt, J. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11111185 · Cited by 28 · see citing works

Genetic dysregulation of EP300 in cancers in light of cancer epigenome control – targeting of p300-proficient and -deficient cancers

Gronkowska, K., & Robaszkiewicz, A. (2024) · Molecular Therapy Oncology · doi:10.1016/j.omton.2024.200871 · Cited by 26 · see citing works

KDM6A regulates immune response genes in multiple myeloma

Dupéré-Richer, D., Riva, A., Maji, S., Barwick, B. G., Román, H. L. C., Sobh, A., Quickstad, G., Li, J., De, U., Piper, C., et al. (2024) · Blood · doi:10.1182/blood.2024024518 · Cited by 22 · see citing works

LncRNA MIR31HG fosters stemness malignant features of non-small cell lung cancer via H3K4me1- and H3K27Ace-mediated GLI2 expression

Chen, W., Wang, F., Yu, X., Qi, J., Dong, H., Cui, B., Zhang, Q., Wu, Y., An, J., Ni, N., et al. (2023) · Oncogene · doi:10.1038/s41388-023-02883-4 · Cited by 22 · see citing works

H3K18 lactylation-mediated SIX1 upregulation contributes to silica-induced epithelial-mesenchymal transition in airway epithelial cells

Liu, S., He, Y., Jin, L., Shi, S., Zhang, J., Xie, W., Yang, M., Zhang, Q., & Kong, H. (2025) · Toxicology · doi:10.1016/j.tox.2025.154109 · Cited by 21 · see citing works

CRISPR/Cas9 technology: applications in oocytes and early embryos

Zhang, Y., Yin, T., & Zhou, L. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04610-9 · Cited by 25 · see citing works

Chromatin-based memory as a self-stabilizing influence on cell identity

Bell, C. C., Faulkner, G. J., & Gilan, O. (2024) · Genome biology · doi:10.1186/s13059-024-03461-x · Cited by 20 · see citing works

HDAC8 drives spindle organization during meiotic maturation of porcine oocytes

Chen, Y., Pan, C., Lu, Y., Miao, Y., & Xiong, B. (2021) · Cell Proliferation · doi:10.1111/cpr.13119 · Cited by 20 · see citing works

Hepatic NCoR1 deletion exacerbates alcohol-induced liver injury in mice by promoting CCL2-mediated monocyte-derived macrophage infiltration

Yin, F., Wu, M., Wei, X., Ren, R., Liu, M., Chen, C., Liu, Y., Xie, R.-Q., Jiang, S., Wang, X.-F., et al. (2022) · Acta Pharmacologica Sinica · doi:10.1038/s41401-022-00863-0 · Cited by 20 · see citing works

CREBBP/EP300 acetyltransferase inhibition disrupts FOXA1-bound enhancers to inhibit the proliferation of ER+ breast cancer cells

Bommi‐Reddy, A., Park-Chouinard, S., Mayhew, D. N., Terzo, E., Hingway, A., Steinbaugh, M. J., Wilson, J. E., Sims, R. J., & Conery, A. R. (2022) · PLoS ONE · doi:10.1371/journal.pone.0262378 · Cited by 19 · see citing works

Incomplete erasure of histone marks during epigenetic reprogramming in medaka early developmentPreprint

Fukushima, H. S., Takeda, H., & Nakamura, R. (2023) · Genome Research · doi:10.1101/gr.277577.122 · Cited by 19 · see citing works

Catalytic-dependent and independent functions of the histone acetyltransferase CBP promote pioneer factor-mediated zygotic genome activation

Marsh, A. J., Пирогов, С. А., Kaur, Y., Ruffridge, A. J., Sajwan, S., Gibson, T. J., Hunt, G., Harrison, M. M., & Mannervik, M. (2024) · Molecular Cell · doi:10.1016/j.molcel.2025.05.009 · Cited by 22 · see citing works

High levels of Histone H3 K27 acetylation and tri-methylation are associated with shorter survival in Oral Squamous Cell Carcinoma patients

Shahhosseini, A., a-Flin, E. B., Derakhshan, S., Aminishakib, P., & Goudarzi, A. (2023) · Biomedicine · doi:10.37796/2211-8039.1391 · Cited by 17 · see citing works

Regulation of SUMOylation on RNA metabolism in cancers

Cao, Y., Huang, C., Zhao, X., & Yu, J. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1137215 · Cited by 17 · see citing works

Activation, decommissioning, and dememorization: enhancers in a life cycle

Wu, X., Wu, X., & Xie, W. (2023) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2023.04.005 · Cited by 15 · see citing works

Functional inversion of circadian regulator REV-ERBα leads to tumorigenic gene reprogramming

Yang, Y., Zhang, X., Cai, D., Zheng, X., Zhao, X., Zou, J. X., Zhang, J., Borowsky, A. D., Dall’Era, M., Corey, E., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2411321121 · Cited by 16 · see citing works

Plasma Cell–Free DNA Chromatin Immunoprecipitation Profiling Depicts Phenotypic and Clinical Heterogeneity in Advanced Prostate Cancer

Sipola, J., Munzur, A. D., Kwan, E. M., Seo, C. C. Y., Hauk, B. J., Parekh, K., Liao, Y. J., Bernales, C. Q., Donnellan, G., Bloise, I., et al. (2024) · Cancer Research · doi:10.1158/0008-5472.can-24-2052 · Cited by 18 · see citing works

Comparative Analysis of Drug-like EP300/CREBBP Acetyltransferase Inhibitors

Crawford, M. C., Tripu, D. R., Barritt, S. A., Jing, Y., Gallimore, D., Kales, S. C., Bhanu, N. V., Xiong, Y., Fang, Y., Butler, K. A. T., et al. (2023) · ACS Chemical Biology · doi:10.1021/acschembio.3c00293 · Cited by 15 · see citing works

Histone methylation and acetylation in cancer: mechanism, progression, and targets

Bu, S., Ye, T., Gao, H., Song, H., & Zhu, Y. (2024) · ONCOLOGIE · doi:10.1515/oncologie-2024-0324 · Cited by 14 · see citing works

Ncor1 Deficiency Promotes Osteoclastogenesis and Exacerbates Periodontitis

Ma, X. X., Meng, X.-Q., Wang, Y., Liu, Y., Shi, X., Shao, S., Duan, S., & Lu, H. (2022) · Journal of Dental Research · doi:10.1177/00220345221116927 · Cited by 14 · see citing works

Novel insights into lncRNAs as key regulators of post-translational modifications in cancer: mechanisms and therapeutic potential

Han, Y., Li, S., Oyang, L., Cui, S., Zhang, W., Yang, W., Peng, M., Tan, S., Xia, L., Lin, J., et al. (2025) · Cellular Oncology · doi:10.1007/s13402-025-01086-1 · Cited by 14 · see citing works

Histone methylation modification and diabetic kidney disease: Potential molecular mechanisms and therapeutic approaches (Review)

Qu, P., Li, L., Jin, Q., Liu, D., Qiao, Y., Zhang, Y., Sun, Q., Ran, S., Li, Z., Liu, T., et al. (2024) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2024.5428 · Cited by 13 · see citing works

Epigenetic programming of TBX2/CX43 mediates lower sperm quality in male offspring induced by prenatal dexamethasone exposure

Liu, Y., Liu, Y., Chen, G., & Wang, H. (2023) · Toxicological Sciences · doi:10.1093/toxsci/kfad016 · Cited by 13 · see citing works

VGLL2 and TEAD1 fusion proteins identified in human sarcoma drive YAP/TAZ-independent tumorigenesis by engaging EP300Preprint

Guo, S., Hu, X., Cotton, J. L., Ma, L., Li, Q., Cui, J., Wang, Y., Thakare, R., Tao, Z., Ip, Y. T., et al. (2024) · eLife · doi:10.7554/elife.98386 · Cited by 13 · see citing works

Identification of molecular determinants of gene-specific bursting patterns by high-throughput imaging screens

Sood, V., Holewinski, R. J., Andrésson, Þ., Larson, D. R., & Misteli, T. (2025) · Molecular Cell · doi:10.1016/j.molcel.2025.01.022 · Cited by 16 · see citing works

The histone modifier KAT2A presents a selective target in a subset of well-differentiated microsatellite-stable colorectal cancers

Kufrin, V., Seiler, A., Brilloff, S., Rothfuß, H., Küchler, S., Schäfer, S., Rahimian, E., Baumgarten, J., Ding, L., Buchholz, F., et al. (2025) · Cell Death and Differentiation · doi:10.1038/s41418-025-01479-7 · Cited by 11 · see citing works

Unravelling the Role of P300 and TMPRSS2 in Prostate Cancer: A Literature Review

Gioukaki, C., Georgiou, A., Gkaralea, L. E., Κroupis, C., Lazaris, A. C., Alamanis, C., & Thomopoulou, G. E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411299 · Cited by 11 · see citing works

EP300 promotes lung cancer cell proliferation by regulating the oncogenic transcription of Hippo-YAP signaling pathway

Li, S., Shi, J., Wang, L., Zhang, D., & Zhang, H. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.149330 · Cited by 11 · see citing works

EP300/CREBBP acetyltransferase inhibition limits steroid receptor and FOXA1 signaling in prostate cancer cells

Huttunen, J., Aaltonen, N., Helminen, L., Rilla, K. J., & Paakinaho, V. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05209-z · Cited by 10 · see citing works

Histone deacetylase 3 inhibition alleviates 2,4-dinitrochlorobenzene-induced atopic dermatitis via epigenetically upregulating Nrf2/HO-1 signaling pathway

Zhou, W., Zeng, D., Liu, S., Huang, Y., Lv, F., & Zhou, W. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.111107 · Cited by 9 · see citing works

Bromodomain inhibitor treatment leads to overexpression of multiple kinases in cancer cells

Chandrashekar, D. S., Afaq, F., Karthikeyan, S. K., Athar, M., Shrestha, S., Singh, R., Manne, U., & Varambally, S. (2024) · Neoplasia · doi:10.1016/j.neo.2024.101046 · Cited by 9 · see citing works

It’s all in the combination: decoding the epigenome for cancer research and diagnostics

Furth, N., & Shema, E. (2022) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2022.101899 · Cited by 9 · see citing works

Distinct modulation of IFNγ-induced transcription by BET bromodomain and catalytic P300/CBP inhibition in breast cancer

Hogg, S. J., Motorna, O., Kearney, C. J., Derrick, E. B., House, I. G., Todorovski, I., Kelly, M. J., Zethoven, M., Bromberg, K. D., Lai, A., et al. (2022) · Clinical Epigenetics · doi:10.1186/s13148-022-01316-5 · Cited by 8 · see citing works

LncRNA-Histone Modification Crosstalk: Orchestrating Cancer Pathobiology

Jasim, S. A., Pallathadka, H., Hjazi, A., Sanghvi, G. V., Rekha, M. M., Agarwal, M., Arya, R., Alasheqi, M. Q., KADHIM, A. J., & Kariem, M. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04402-6 · Cited by 8 · see citing works

Expanding the landscape of lysine acetylation stoichiometry and clinical impact

Encarnación‐Guevara, S., & Gil, J. (2025) · Journal of Proteomics · doi:10.1016/j.jprot.2025.105522 · Cited by 10 · see citing works

The adverse effects of developmental exposure to polystyrene nanoparticles on cognitive function in weaning rats and the protective role of trihydroxy phenolacetone

Wang, H., Qiao, C., Gao, Y., Geng, Y., Niu, F., Yang, R., Wang, Z., Jiang, W., & Sun, H. (2024) · Environmental Pollution · doi:10.1016/j.envpol.2024.123632 · Cited by 8 · see citing works

FAK-LINC01089 negative regulatory loop controls chemoresistance and progression of small cell lung cancer

Wang, X., Li, X., Niu, L., Lv, F., Guo, T., Gao, Y., Ran, Y., Huang, W., & Wang, B. (2024) · Oncogene · doi:10.1038/s41388-024-03027-y · Cited by 9 · see citing works

Epigenetic reprogramming in multiple myeloma—Challenges and opportunities

Kumar, S., Kats, L. M., & Gruber, E. (2025) · International Journal of Cancer · doi:10.1002/ijc.35426 · Cited by 7 · see citing works

Metabolite-derived protein modifications modulating oncogenic signaling

Liu, Y., Vandekeere, A., Xu, M., Fendt, S., & Altea‐Manzano, P. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.988626 · Cited by 7 · see citing works

TMEM120A-mediated regulation of chemotherapy sensitivity in colorectal cancer cells

Wang, L., & Liu, X. (2023) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-023-04594-9 · Cited by 7 · see citing works

SEMA3C promotes thyroid cancer via the Wnt/β-catenin pathway

Li, S., Cheng, Y., Gao, C., Yuan, Q., & Lu, X. (2024) · Experimental Cell Research · doi:10.1016/j.yexcr.2024.114378 · Cited by 6 · see citing works

Development of p300-targeting degraders with enhanced selectivity and onset of degradation

Marsh, G. P., Cooper, M. S., Goggins, S., Reynolds, S. J., Wheeler, D. F., Cresser-Brown, J. O., Arnold, R. E., Babcock, E. G., Hughes, G., Bosnakovski, D., et al. (2025) · RSC Medicinal Chemistry · doi:10.1039/d4md00969j · Cited by 6 · see citing works

Histone Deacetylase 2 in Alzheimer’s Disease: A Comprehensive Molecular Blueprint for Therapeutic Targeting

Asadi, K., Radha, K., Satarker, S., & Gurram, P. C. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05264-y · Cited by 6 · see citing works

Co-activation of the super-enhancer complex SOX2 and HDAC1 confers temozolomide resistance by promoting PDGFB transcription in glioblastoma

Xie, H., Ji, T., Zhang, C., Cheng, M., Wang, R., Wu, Y., Wang, J., Wang, H., Yang, J., Xu, S., et al. (2025) · Neuro-Oncology · doi:10.1093/neuonc/noaf219 · Cited by 6 · see citing works

Histone acetylation homeodynamics navigates cell survival and apoptosis

Li, K., Tian, L., Cao, W., Zhang, J., Zhang, W., Lin, T., Huang, S., Qiu, Y., Ruan, Z., Deng, J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-66405-4 · Cited by 6 · see citing works

Genetic and Epigenetic Mechanisms Underlying Reversible Adaptive Responses in Fungi

Dan, L., Liu, S., Qiang, Z., Ye, X., & Zhang, J. (2026) · Journal of Fungi · doi:10.3390/jof12050309 · Cited by 8 · see citing works

Therapeutic Discovery for Chromatin Complexes: Where Do We Stand?

Owens, D. D. G., Maitland, M. E. R., Arrowsmith, C. H., & Baršytė-Lovejoy, D. (2024) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-062822-110356 · Cited by 7 · see citing works

Scaffold proteins of cancer signaling networks: The paradigm of FK506 binding protein 51 (FKBP51) supporting tumor intrinsic properties and immune escape

Marrone, L., D’Agostino, M., Giordano, C., Giacomo, V. D., Urzini, S., Malasomma, C., Gammella, M., Tufano, M., Romano, S., & Romano, M. F. (2023) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.32604/or.2023.028392 · Cited by 6 · see citing works

Tissue-scale mechanics controls differentiation strategy and dynamics of epithelial multilayeringPreprint

Villeneuve, C., Azote, S., Albu, M., Rübsam, M., Biggs, L. C., Vinzens, S., Kruse, K., Prakash, A., Zentis, P., Lawson-Keister, E., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.08.704529 · Cited by 6 · see citing works

Acetylation and deacetylation dynamics in stress response to cancer and infections

Li, L., Zeng, Y., Cheng, G., & Yang, H. (2025) · Seminars in Immunology · doi:10.1016/j.smim.2025.101957 · Cited by 5 · see citing works

High fructose promotes MYCN-amplified neuroblastoma progression through NgBR-ACSS2-mediated biosynthesis of acetyl-CoA

Hu, W., Wang, X., Fang, Z. H., Zhang, J., Tirumalasetty, M. B., & Miao, Q. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115947 · Cited by 5 · see citing works

Valemetostat–SAHA-Driven Acetylation of p53 via SET/TAF-Iβ Displacement and p300 Activation Modulates Cell Cycle Regulators in Pancreatic Cancer Cells

Crosta, M. D., Ragone, F. C., Benedetti, R., D’Orazi, G., Santarelli, R., Montani, M. S. G., & Cirone, M. (2025) · Biomedicines · doi:10.3390/biomedicines13092279 · Cited by 5 · see citing works

The interplay of epigenetic remodelling and transposon-mediated genomic instability in ageing and longevity

Lemus, A. J. J., Tewelde, E., Bhala, R., Guan, A., Xu, A., & Benayoun, B. A. (2026) · Open Biology · doi:10.1098/rsob.250093 · Cited by 5 · see citing works

BRD4 orchestrates the metabolic-epigenetic regulation of GM-CSF expression and secretion to drive PD-L1⁺ macrophage-mediated immune evasion in triple-negative breast cancer

Diao, H., Chen, J., Zhang, Y., Hua, H., Dong, M., Jin, W., Chen, J., Shan, B., Cao, Y., Han, X., et al. (2026) · Oncogene · doi:10.1038/s41388-026-03681-4 · Cited by 5 · see citing works

BANCR-containing extracellular vesicles enhance breast cancer resistance

Song, X., Liu, S., Zeng, Y., Cai, Y., & Luo, H. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.108304 · Cited by 5 · see citing works

[Coactivator p300-induced H3K27 acetylation mediates lipopolysaccharide-induced inflammatory mediator synthesis].

Hu, K., Cao, X., Li, Y., Liu, L., Chen, Y., Chen, L., Huang, M., Tan, B., & Yin, H. (2022) · PubMed Central · doi:10.12122/j.issn.1673-4254.2022.03.02 · Cited by 5 · see citing works

New Inhibitors of the Human p300/CBP Acetyltransferase Are Selectively Active against the Arabidopsis HAC Proteins

Longo, C., Lepri, A., Paciolla, A., Messore, A., Vita, D. D., di Patti, M. C. B., Amadei, M., Madia, V. N., Ialongo, D., Santo, R. D., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810446 · Cited by 5 · see citing works

Epigenetic dysregulation of energy homeostasis drives aortic valve stenosis that is treatable with metformin

Cashman, T. J., Saheera, S., Blau, A., Otabil, E. M., Nagy, N. Y., Samenuk, T. D., Fitzgibbons, T. P., McManus, D. D., & Trivedi, C. M. (2025) · JCI Insight · doi:10.1172/jci.insight.188562 · Cited by 4 · see citing works

NAA10 (N-Alpha-Acetyltransferase 10): A Multifunctional Regulator in Development, Disease, and Cancer

Yang, Z. Q., Campeanu, I. J., Lopez, I., Syed, M., Jiang, Y., & Afisllari, H. (2025) · Cells · doi:10.3390/cells14120863 · Cited by 4 · see citing works

GALNT4 promotes the stemness of non-small cell lung cancer through O-glycosylation of MUC5AC via ITGB4/PI3K/AKT signaling pathway

Guo, Y., Xing, R., Li, Q., Zhou, W., Qi, X., & Li, S. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.111934 · Cited by 4 · see citing works

Decreased adenosine 3′,5′-cyclic monophosphate is a driving factor of P300/SIRT1-mediated histone hyperacetylation in obesity-related hypertension

Wang, Y., Zhang, Q., Shen, C., Wang, H., Li, Y., Wu, H., Sun, X., & Shi, L. (2025) · Journal of Hypertension · doi:10.1097/hjh.0000000000003981 · Cited by 4 · see citing works

Catching active enhancers via H2B N-terminal acetylation

Huang, C., & Helin, K. (2023) · Nature Genetics · doi:10.1038/s41588-023-01347-5 · Cited by 4 · see citing works

Transcriptional synergy in human aortic endothelial cells is vulnerable to combination p300/CBP and BET bromodomain inhibition

Bracken, R. C., Davison, L. M., Buehler, D. P., Fulton, M. E., Carson, E. E., Sheng, Q., Stolze, L. K., Guillermier, C., Steinhauser, M. L., & Brown, J. D. (2024) · iScience · doi:10.1016/j.isci.2024.110011 · Cited by 4 · see citing works

The important role of the histone acetyltransferases p300/CBP in cancer and the promising anticancer effects of p300/CBP inhibitors

Wu, X., Zhang, X., Tang, S., & Wang, Y. (2025) · Cell Biology and Toxicology · doi:10.1007/s10565-024-09984-0 · Cited by 28 · see citing works

P300/CBP acetyltransferase inhibition and degradation disrupt oncogenic transcriptional programs and reveal epigenetic vulnerabilities in multiple myeloma

Motorna, O., Hogg, S. J., Todorovski, I., Cluse, L. A., Shortt, J., & Johnstone, R. W. (2025) · Blood · doi:10.1182/blood-2025-5717

Abstract LB-A23: Discovery of a potent catalytic p300/CBP inhibitor that targets lineage-specific tumors

Bromberg, K. D., Lasko, L. M., Jakob, C. G., Qiu, W., Montgomery, D., DiGiammarino, E. L., Hansen, T. M., Risi, R. M., Frey, R. R., Manaves, V., et al. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.targ-17-lb-a23

Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours

Lasko, L. M., Jakob, C. G., Edalji, R. P., Qiu, W., Montgomery, D., Digiammarino, E. L., Hansen, T. M., Risi, R. M., Frey, R., Manaves, V., et al. (2017) · Nature · doi:10.1038/nature24028 · Cited by 858 · see citing works

Dysregulation of the p300/CBP histone acetyltransferases in human cancer

Xu, L., Xuan, H., & Shi, X. (2024) · Epigenomics · doi:10.1080/17501911.2024.2447807 · Cited by 13 · see citing works